Diagnostic pitfalls in a young adult with new diabetes.


Journal

Endocrinology, diabetes & metabolism case reports
ISSN: 2052-0573
Titre abrégé: Endocrinol Diabetes Metab Case Rep
Pays: England
ID NLM: 101618943

Informations de publication

Date de publication:
01 Oct 2023
Historique:
received: 17 02 2023
accepted: 20 09 2023
medline: 19 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: epublish

Résumé

A 20-year-old South Asian male presented with polyuria, polydipsia, HbA1c 81 mmol/mol, BMI 28.8 and family history of both type 1 and type 2 diabetes mellitus. As autoantibody testing was negative and c-peptide level demonstrated significant endogenous insulin secretion, type 1 diabetes was excluded. Given his age and family history, the differential diagnosis included maturity-onset diabetes of the young (MODY), a rare form of diabetes caused by a single-gene variant. A high probability of MODY was calculated and he was subsequently referred for genetic testing. Although a useful tool, the pre-test probability calculator for MODY is only validated in White Europeans. A heterogenous variant of unknown clinical significance of the NEUROD1 gene was detected, leading to gliclazide use with poor response. The patient responded well to metformin. Type 2 diabetes was considered the most likely diagnosis. This case highlights the diagnostic challenges in young patients of Asian ethnicity and the importance of interpreting genetic results of unknown significance within the clinical context. Ethnicity-specific BMI thresholds should be used when classifying patients as overweight or obese. Variants of unknown significance detected by genetic sequencing should be interpreted within the context of the patient's other clinical parameters. It is important to use ethnicity-specific BMI thresholds for obesity. Diagnosis of type 2 diabetes mellitus at younger ages is becoming increasingly common. The pre-test probability calculator for MODY is only validated in White Europeans; although a useful guide, results should be interpreted with caution in patients of other ethnicities.

Identifiants

pubmed: 37855645
doi: 10.1530/EDM-23-0024
pii: 23-0024
pmc: PMC10620446
doi:
pii:

Types de publication

Journal Article

Langues

eng

Références

Lancet Diabetes Endocrinol. 2018 Jan;6(1):69-80
pubmed: 28847479
Curr Diab Rep. 2019 Feb 22;19(3):12
pubmed: 30793219
Diabetes Ther. 2020 Aug;11(8):1667-1685
pubmed: 32583173
Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):200-13
pubmed: 18301398
Diabetes Metab Syndr Obes. 2019 Jul 08;12:1047-1056
pubmed: 31360071
Endocrinol Diabetes Metab. 2022 Sep;5(5):e00332
pubmed: 35822264
Diabetologia. 2012 May;55(5):1265-72
pubmed: 22218698
Lancet Diabetes Endocrinol. 2021 Jul;9(7):419-426
pubmed: 33989535
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Nature. 2020 May;581(7809):434-443
pubmed: 32461654

Auteurs

Natalie Below (N)

Diabetes Centre, Gartnavel General Hospital, Glasgow, UK.
University of Glasgow, Glasgow, UK.

Deborah Morrison (D)

Diabetes Centre, Gartnavel General Hospital, Glasgow, UK.

Ruth McGowan (R)

West of Scotland Centre for Genomic Medicine, Glasgow, UK.

Gregory C Jones (GC)

Diabetes Centre, Gartnavel General Hospital, Glasgow, UK.

Classifications MeSH